GO:0036336 dendritic cell migration: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036336 dendritic cell migration describes the movement of dendritic cells within and between tissues, a process essential for immune surveillance and adaptive immunity initiation [1, 7].
• Dendritic cell migration depends on chemokine gradients, adhesion molecules, and cytoskeletal remodeling, with CCR7 guiding lymph node homing [1, 4].
• Distinct dendritic cell subsets exhibit specialized migratory routes and functions, influencing immune tolerance versus activation [5, 3].
• Dysregulated dendritic cell migration contributes to cancer progression, autoimmunity, and chronic inflammation [2, 6].
• CRISPR-based models (knockout, knock-in, overexpression) enable causal dissection of genes controlling dendritic cell migration [4, 7].
• Key experimental approaches include live imaging, flow cytometry, transcriptomics, and chemotaxis assays to quantify migration [1, 8].
Description
Dendritic cells (DCs) are professional antigen-presenting cells that bridge innate and adaptive immunity. Their ability to migrate from peripheral tissues to lymphoid organs is fundamental for initiating T cell responses and maintaining tolerance [1, 7]. The Gene Ontology term GO:0036336, dendritic cell migration, captures the directed movement of DCs within and between tissues and organs, a process critical for immune surveillance and homeostasis. Dysregulation of DC migration is implicated in cancer immune evasion, autoimmune diseases, and chronic inflammatory conditions [2, 6]. Understanding the molecular players and regulatory mechanisms of DC migration is therefore essential for developing targeted immunotherapies and vaccines [3, 4]. This article synthesizes current knowledge from authoritative literature to provide a research-grade overview of GO:0036336, highlighting key genes, experimental models, and CRISPR-based strategies for functional interrogation.
dendritic cell migration At A Glance
| GO ID | GO:0036336 |
|---|---|
| GO term | dendritic cell migration |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of dendritic cells within and between tissues for immune surveillance and antigen presentation |
| Key chemokine receptors | CCR7, CCR2, CX3CR1, CCR5, CCR6 |
| Key adhesion molecules | Integrins (LFA-1, VLA-4), selectins, ICAM-1 |
| Associated diseases | Cancer, autoimmunity, chronic inflammation, infection |
| Research methods | Live imaging, flow cytometry, chemotaxis assays, transcriptomics, CRISPR screens |
What Is GO:0036336?
GO:0036336 dendritic cell migration is defined as the movement of a dendritic cell within or between different tissues and organs of the body. This biological process encompasses the directed locomotion of dendritic cells from their sites of origin or antigen capture to secondary lymphoid organs, as well as their interstitial migration within peripheral tissues. It is a dynamic, multi-step process involving chemokine sensing, adhesion, cytoskeletal rearrangement, and tissue remodeling [1, 4].
Why Is dendritic cell migration Important in Cell Biology?
Dendritic cell migration is a cornerstone of immune function, enabling DCs to transport antigens from peripheral tissues to lymph nodes where they prime naive T cells. This process is essential for protective immunity against pathogens and for immune tolerance, and its dysregulation underlies numerous pathologies including cancer, autoimmunity, and inflammatory diseases [1, 2, 6]. Understanding the molecular mechanisms of DC migration can inform the design of vaccines, immunotherapies, and treatments for inflammatory disorders [3, 7].
• Initiates adaptive immunity by delivering antigens to lymph nodes [1, 7].
• Maintains immune tolerance by transporting self-antigens and promoting regulatory T cell responses [1, 5].
• Enables immune surveillance of peripheral tissues for pathogens and transformed cells.
• Dysregulated in cancer, where tumor-associated DCs often show impaired migration, contributing to immune evasion [2, 3].
• Contributes to autoimmune diseases such as multiple sclerosis and rheumatoid arthritis through aberrant DC trafficking [1, 6].
• Plays a role in chronic inflammatory conditions like asthma and colitis.
• Target for vaccine adjuvants that aim to enhance DC migration to lymph nodes.
• Provides a model system to study chemokine gradients, cell adhesion, and cytoskeletal dynamics [4, 8].
• Influenced by metabolic and environmental cues, linking immunity to systemic physiology.
• Offers opportunities for CRISPR-based functional genomics to identify novel regulators [4, 7].
What Happens During dendritic cell migration?
Antigen capture and activation in peripheral tissues
In simple terms: Dendritic cells sample their surroundings and become activated when they encounter danger signals.
Immature dendritic cells reside in peripheral tissues where they capture antigens and sense inflammatory or microbial stimuli. Upon activation, they undergo a maturation program that upregulates chemokine receptors such as CCR7, which directs them toward lymphatic vessels [1, 4]. This step is critical for initiating migration and is regulated by pattern recognition receptors and cytokines.
Chemokine sensing and directed migration
In simple terms: Dendritic cells follow chemical trails to find their way to lymph nodes.
Migrating DCs respond to gradients of chemokines such as CCL19 and CCL21, which are produced in lymphoid organs and lymphatic vessels. CCR7 expressed on mature DCs binds these chemokines, triggering intracellular signaling that leads to actin polymerization and directional movement [1, 4]. Other chemokine receptors, including CCR2, CX3CR1, and CCR5, guide DCs in specific contexts such as inflammation.
Adhesion and transmigration through lymphatic endothelium
In simple terms: Dendritic cells squeeze through blood or lymphatic vessel walls to enter circulation.
To enter lymphatic vessels, DCs interact with endothelial cells via adhesion molecules such as ICAM-1 and integrins like LFA-1 and VLA-4. This interaction facilitates transmigration across the endothelium, a process that requires cytoskeletal rearrangements and matrix metalloproteinases [4, 8]. Once in the lymphatic lumen, DCs are carried by lymph flow toward the draining lymph node.
Arrival and positioning in lymph nodes
In simple terms: Once in the lymph node, dendritic cells find the right spot to present antigens.
Within the lymph node, DCs migrate to specific zones, such as the T cell area, guided by chemokine gradients including CCL19 and CCL21. This positioning allows them to interact with naive T cells and initiate adaptive immune responses [1, 7]. The process is highly regulated and involves interactions with stromal cells and extracellular matrix components.
Key Genes Involved in GO:0036336 dendritic cell migration
The following genes and proteins are central to dendritic cell migration, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCR7 | Chemokine receptor for CCL19/CCL21; directs lymph node homing | Key marker of mature DCs; knockout impairs migration [1, 4] |
| CCL19 | Chemokine ligand for CCR7; produced in lymph nodes | Gradient formation; overexpression enhances migration |
| CCL21 | Chemokine ligand for CCR7; expressed in lymphatic endothelium | Guides DC entry into lymphatics [1, 4] |
| CCR2 | Receptor for CCL2; mediates inflammatory DC recruitment | Involved in monocyte-derived DC migration |
| CX3CR1 | Fractalkine receptor; promotes DC survival and migration | Associated with tolerogenic DCs |
| CCR5 | Receptor for CCL3/CCL4/CCL5; inflammatory DC trafficking | Linked to DC recruitment in infection |
| CCR6 | Receptor for CCL20; mucosal DC migration | Important for mucosal immunity |
| ITGAL (LFA-1) | Integrin mediating adhesion to ICAM-1 | Required for transmigration |
| ITGB1 (VLA-4) | Integrin binding fibronectin and VCAM-1 | Facilitates interstitial migration |
| ICAM1 | Adhesion molecule on endothelial cells | Supports DC adhesion and transmigration |
| MMP9 | Matrix metalloproteinase; degrades extracellular matrix | Enables DC migration through tissues |
| CDC42 | Rho GTPase regulating actin dynamics | Controls DC motility |
| RAC1 | Rho GTPase involved in lamellipodia formation | Essential for directed migration |
| RHOA | Rho GTPase regulating actomyosin contraction | Modulates DC migration speed |
| ACTB | Beta-actin; cytoskeletal component | Required for cell motility |
| MYH9 | Non-muscle myosin heavy chain; contractility | Influences DC migration mechanics |
| PIK3CD | PI3K catalytic subunit; signaling downstream of chemokine receptors | Regulates actin polymerization |
| PTK2 (FAK) | Focal adhesion kinase; integrin signaling | Modulates adhesion turnover |
How Is dendritic cell migration Regulated?
Dendritic cell migration is tightly regulated at multiple levels. Chemokine receptor expression is controlled transcriptionally and post-translationally; for example, CCR7 is upregulated upon DC maturation via NF-kB and IRF signaling [1, 4]. Post-translational modifications such as phosphorylation and ubiquitination modulate receptor activity and recycling. Lipid mediators like prostaglandin E2 enhance CCR7 expression and migratory capacity. Metabolic cues, including hypoxia and mTOR signaling, also influence DC migration by altering cytoskeletal dynamics and energy supply. Additionally, interactions with extracellular matrix components and stromal cells provide spatial and mechanical regulation [1, 5].
dendritic cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCR7 | Cancer immune evasion; impaired lymph node homing | Knockout mouse models; CRISPR KO in DC cell lines [2, 4] |
| CCR2 | Autoimmune neuroinflammation; multiple sclerosis | Point mutation knock-in mice; CCR2 antagonist studies |
| CCL19 | Tumor microenvironment; reduced DC recruitment | Overexpression models; chemokine gradient assays |
| CX3CR1 | Chronic inflammation; colitis | Knock-in reporter mice; CRISPR tagging |
| MMP9 | Cancer metastasis; DC migration through matrix | Knockout and point mutation models |
Dendritic cell migration in cancer
In cancer, dendritic cell migration is often dysregulated, leading to impaired antigen presentation and immune evasion. Tumor-derived factors can alter chemokine gradients and downregulate CCR7 on DCs, reducing their ability to reach lymph nodes [2, 3]. Conversely, certain tumors recruit tolerogenic DCs that promote regulatory T cell responses and suppress anti-tumor immunity. Understanding these mechanisms is critical for developing DC-based cancer vaccines and immunotherapies.
Dendritic cell migration in autoimmunity
Aberrant dendritic cell migration contributes to autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. In these conditions, DCs migrate excessively to lymphoid organs and inflamed tissues, presenting self-antigens and activating autoreactive T cells [1, 6]. Targeting chemokine receptors like CCR7 or CCR2 has been explored as a therapeutic strategy to limit pathological DC trafficking.
Dendritic cell migration in chronic inflammation
Chronic inflammatory diseases, including asthma and inflammatory bowel disease, are characterized by increased recruitment of dendritic cells to affected tissues. This migration is driven by chemokines such as CCL20 and CCL2, which attract CCR6+ and CCR2+ DCs. Modulating these pathways could reduce inflammation and tissue damage.
From dendritic cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CCR7 impair DC migration to lymph nodes? | CCR7 knockout mouse or CRISPR KO in DC cell lines [1, 4] |
| How does a point mutation in CCR7 affect ligand binding? | CRISPR point mutation knock-in in primary DCs |
| Can overexpression of CCL21 enhance DC recruitment? | Transgenic overexpression or lentiviral delivery |
| What is the role of CX3CR1 in tolerogenic DC migration? | CX3CR1-GFP knock-in reporter mice |
| Which genes regulate DC migration in tumors? | Genome-wide CRISPR library screening in DC lines [4, 7] |
| How does metabolic stress affect DC motility? | Conditional KO of mTOR or HIF1A in DCs |
How to Study the dendritic cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Intravital microscopy | Real-time DC movement in tissues | Tracking DC migration to lymph nodes |
| Transwell chemotaxis | Directed migration toward chemokines | Assessing CCR7 function |
| Flow cytometry | DC subset frequencies and marker expression | Quantifying migratory DCs |
| RNA-seq | Transcriptional profiles | Identifying migration-associated genes |
| Proteomics | Protein expression and modifications | Discovering signaling changes |
| CRISPR knockout screen | Gene essentiality for migration | Unbiased discovery of regulators |
| Live-cell imaging | Cytoskeletal dynamics | Studying actin remodeling |
| Bioinformatics pathway analysis | Enrichment of migration pathways | Interpreting omics data |
Live imaging and intravital microscopy
Live imaging techniques, such as two-photon intravital microscopy, allow real-time visualization of dendritic cell migration within tissues and lymph nodes. These methods provide spatial and temporal dynamics of DC movement, including speed, directionality, and interactions with other cells [1, 8].
Flow cytometry and chemotaxis assays
Flow cytometry quantifies DC subsets and their expression of chemokine receptors and adhesion molecules. Chemotaxis assays, such as Transwell migration, measure the ability of DCs to migrate toward specific chemokines in vitro, providing functional readouts of migratory capacity [4, 8].
Transcriptomics and proteomics
RNA sequencing and proteomics can identify genes and proteins differentially expressed during DC maturation and migration. These approaches reveal regulatory networks and potential therapeutic targets [2, 4].
CRISPR screens and functional genomics
Pooled CRISPR knockout screens enable unbiased discovery of genes required for DC migration. Combined with bioinformatics, these screens can pinpoint novel regulators and pathways [4, 7].
How CRISPR Can Be Used to Study GO:0036336 dendritic cell migration
Knockout
CRISPR knockout of candidate genes such as CCR7 or MMP9 in dendritic cell lines or primary cells can abolish or reduce migration, providing causal evidence. Knockout models are essential for validating gene function in DC trafficking [4, 7].
Point Mutation
Introducing specific point mutations via CRISPR can dissect the contribution of individual amino acids to chemokine receptor signaling or adhesion molecule function. For example, mutating phosphorylation sites in CCR7 can reveal their role in receptor internalization and migration.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows tracking of endogenous proteins during DC migration. This approach preserves native regulation and enables live imaging of specific genes [5, 7].
Overexpression
CRISPR activation or lentiviral overexpression can increase levels of chemokines or receptors to enhance DC migration. Overexpression models are useful for gain-of-function studies and for testing therapeutic candidates [1, 3].
How EDITGENE Supports dendritic cell migration Research
Researchers studying dendritic cell migration-related genes often need to determine whether a candidate gene is causally involved in migratory behavior. EDITGENE provides a comprehensive suite of CRISPR-based services to interrogate gene function with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for dendritic cell migration research.
Frequently Asked Questions About dendritic cell migration
What is GO:0036336 dendritic cell migration?
GO:0036336 is a Gene Ontology biological process term defined as the movement of a dendritic cell within or between different tissues and organs of the body.
What genes are involved in dendritic cell migration?
Key genes include CCR7, CCL19, CCL21, CCR2, CX3CR1, CCR5, CCR6, ITGAL, ITGB1, ICAM1, MMP9, CDC42, RAC1, RHOA, and PIK3CD, among others [1, 4, 5, 6].
How is dendritic cell migration regulated?
It is regulated by chemokine gradients, adhesion molecules, cytoskeletal dynamics, and signaling pathways such as PI3K and mTOR, as well as transcriptional programs activated during DC maturation [1, 4, 6].
Why is dendritic cell migration important in cancer?
In cancer, impaired DC migration can lead to immune evasion, while tolerogenic DC recruitment can suppress anti-tumor immunity. Understanding these mechanisms is vital for immunotherapy [2, 3].
What methods are used to study dendritic cell migration?
Common methods include intravital microscopy, Transwell chemotaxis assays, flow cytometry, RNA-seq, proteomics, and CRISPR screens [1, 4, 7, 8].
Can CRISPR be used to study dendritic cell migration?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional interrogation of genes involved in DC migration [4, 7].
What are the main steps of dendritic cell migration?
The process includes antigen capture and activation in peripheral tissues, chemokine sensing, adhesion and transmigration through lymphatic endothelium, and arrival and positioning in lymph nodes [1, 4, 7].
Which chemokine receptor is most important for dendritic cell migration to lymph nodes?
CCR7 is considered the master regulator of DC homing to lymph nodes, responding to CCL19 and CCL21 [1, 4].
How does dendritic cell migration contribute to autoimmune diseases?
Aberrant DC migration can lead to excessive presentation of self-antigens and activation of autoreactive T cells, contributing to diseases like multiple sclerosis and rheumatoid arthritis [1, 6].
What experimental models are available for studying dendritic cell migration?
Models include knockout mice, knock-in reporter mice, CRISPR-edited cell lines, and in vitro chemotaxis systems [4, 5, 7].
Conclusion
Dendritic cell migration (GO:0036336) is a fundamental biological process that orchestrates immune surveillance and adaptive immunity. Its dysregulation is linked to cancer, autoimmunity, and chronic inflammation, making it a compelling target for therapeutic intervention. Advances in CRISPR-based gene editing and functional genomics provide powerful tools to dissect the molecular mechanisms of DC migration. EDITGENE offers a comprehensive portfolio of CRISPR services to support researchers in uncovering novel regulators and translating these findings into clinical applications.
References
- 1. Worbs T et al.. 2017. Dendritic cell migration in health and disease.. Nat Rev Immunol 17(1):30-48 PMID: 27890914
- 2. Moon CY et al.. 2025. Dendritic cell maturation in cancer.. Nat Rev Cancer 25(4):225-248 PMID: 39920276
- 3. Del Prete A et al.. 2023. Dendritic cell subsets in cancer immunity and tumor antigen sensing.. Cell Mol Immunol 20(5):432-447 PMID: 36949244
- 4. de Winde CM et al.. 2020. Molecular mechanisms of dendritic cell migration in immunity and cancer.. Med Microbiol Immunol 209(4):515-529 PMID: 32451606
- 5. Balan S et al.. 2019. Dendritic cell subsets and locations.. Int Rev Cell Mol Biol 348:1-68 PMID: 31810551
- 6. Meloun A et al.. 2025. Beyond CCR7: dendritic cell migration in type 2 inflammation.. Front Immunol 16:1558228 PMID: 40093008
- 7. Olson EC et al.. 2026. Dendritic Cell Migration: An Essential Step in Initiating Adaptive Immunity Across Tissues.. Immunol Rev 337(1):e70080 PMID: 41319117
- 8. Martín-Fontecha A et al.. 2009. Dendritic cell migration to peripheral lymph nodes.. Handb Exp Pharmacol PMID: 19031020
